ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Age factors"

  • 2020 American Transplant Congress

    Factors Influencing Background Cell-Free DNA Levels: Implications for Donor-Derived Cell-Free DNA Assessment in Transplant Patients

    P. Gauthier, A. Aleshin, S. Shchegrova, T. Mckenna, E. Kalashnikova, S. Sharma, H. Sethi, R. Salari, R. Swenerton, Z. Demko, B. Zimmermann, P. Billings

    Natera, Inc., San Carlos, CA

    *Purpose: Detecting elevated levels of donor-derived cell-free DNA (dd-cfDNA) in the plasma of transplant recipients has been used as a metric to determine graft injury…
  • 2020 American Transplant Congress

    Liver Transplant Outcomes Across the Age Distribution and Interactions with County Health

    S. K. Niazi1, E. Vargas2, A. Spaulding3, J. Crook2, T. Schneekloth4, A. Keaveny5, A. Vasquez6, M. Gentry4, T. Rummans6, C. Taner5

    1Psychiatry & Psychology; Transplantation, Mayo Clinic, Jacksonville, FL, 2Health Sciences Research, Mayo Clinic, Jacksonville, FL, 3Heath Sciences Research, Mayo Clinic, Jacksonville, FL, 4Psychiatry & Psychology, Mayo Clinic, Rochester, MN, 5Transplantation, Mayo Clinic, Jacksonville, FL, 6Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL

    *Purpose: We examined risk of graft failure and patient mortality after liver transplant (LT) across the age continuum and county Health Outcomes & Health Factors…
  • 2020 American Transplant Congress

    From Marginal to Meaningful: Donor Liver Biopsy Increases Donation Rates amongst Elderly Donors

    J. A. Steggerda1, M. B. Bloom1, K. Mahendraraj1, G. Voidonikolas1, T. Todo1, M. Noureddin2, N. N. Nissen1, A. S. Klein1, I. K. Kim1

    1Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, 2Hepatology, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA

    *Purpose: Recently, there has been public scrutiny on the non-utilization of elderly donors in liver transplantation. Here, we evaluate the influence of donor liver biopsy…
  • 2020 American Transplant Congress

    Older Organs Transfer Senescence to Transplant Recipients

    J. Iske1, R. Maenosono1, M. Seyda1, T. Heinbockel1, M. Koichiro1, Y. Nian1, T. Tchkonia2, J. L. Kirkland2, R. Abdi1, A. Elkhal1, S. G. Tullius1

    1Brigham and Women's Hospital, Boston, MA, 2Mayo Clinic, Rochester, MN

    *Purpose: Older organs represent an underutilized potential. Organ age, at the same time, augments alloimmune responses resulting into increased acute rejection rates. Senescent cells accumulate…
  • 2019 American Transplant Congress

    Infectious Complications in Kidney Transplant Recipients Age 65 and Older

    L. E. Liriano-Ward1, M. Barbachan e Silva2, Y. Azzi1, M. Ajaimy1, A. Cambell1, J. Graham1, J. Rocca1, C. Pynadath1, G. Nair1, O. Andacoglu1, S. Greenstein1, P. Ó Broin2, E. Akalin1

    1Transplant, Einstein/Montefiore Medical Center, Bronx, NY, 2School of Mathematics, Statistics & Applied Mathematics, National University of Ireland Galway, Galway, Ireland

    *Purpose: Kidney transplant recipients age 65 years and older are at higher risk for development of infections. We aimed to investigate the incidence of both…
  • 2019 American Transplant Congress

    The Power of Young Donor Liver; Elixir of Life for Sick Liver Transplant Recipient

    J. Kusakabe1, J. McVey2, D. J. Firl2, M. Fujiki2, F. N. Aucejo2, C. Quintini2, K. Hashimoto2, K. Sasaki2

    1Kyoto University Graduate School of Medicine, Kyoto, Japan, 2Cleveland Clinic Foundation, Department of General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH

    *Purpose: Young donor organs are known to have significant prognostic benefits in liver transplantation (LT). However, details of short- and long-term prognostic benefits of young…
  • 2019 American Transplant Congress

    Poor Outcomes in Kidney Transplant Candidates & Recipients with History of Falls

    N. Chu1, H. Ying1, Z. Shi1, C. Haugen1, S. Norman2, D. Segev1, M. McAdams-DeMarco1

    1Johns Hopkins, Baltimore, MD, 2Michigan Medical Center, Ann Arbor, MI

    *Purpose: In patients with ESRD, serious fall injuries (e.g. fractures) are associated with decreased chance of listing or transplantation. It is likely that KT candidates…
  • 2019 American Transplant Congress

    Combined Ischemic and Rapamycin Preconditioning Alleviated Liver Ischemia and Reperfusion Injury by Restoring Autophagy in Old Mice

    Z. Rao, X. Pan, W. Zhong, Z. Ding, H. Zhou, C. Liu

    The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

    *Purpose: Old livers are more damaged by hepatic ischemia and reperfusion (IR) injury than young livers. The aim of this study was to investigate the…
  • 2019 American Transplant Congress

    Outcomes of Liver Transplantation for Hepatocellular Carcinoma in Septuagenarians

    M. Najjar1, K. Bruestle1, P. Jiang1, E. Lieberman1, R. Hwang1, A. Mathur1, E. C. Verna1, A. Griesemer1, B. Samstein2, T. Kato1, Y. M. Saenger1, K. J. Halazun2, J. C. Emond1

    1Columbia University Medical Center, New York, NY, 2Weill Cornell Medicine, New York, NY

    *Purpose: The impact of advanced age on liver transplantation (LT) for hepatocellular carcinoma (HCC) has not been well studied. We sought to compare post-OLT survival…
  • 2019 American Transplant Congress

    Senescent Cell Clearance with Senolytic Drugs Improves Cardiac Allograft Survival by Targeting mt-DNA Mediated Immune Responses

    J. Iske1, M. Koichiro1, M. Seyda1, T. Heinbokel1, Y. Nian1, R. Maenosono1, H. Azuma1, C. Falk2, T. Tchokonia3, J. Kirkland3, A. Elkhal1, S. Tullius1

    1Transplant Surgery, Brigham and Women's Hospital, Boston, MA, 2Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany, 3Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN

    *Purpose: Older organs represent an underutilized potential. We dissected alloimmune responses when transplanting older organs and tested if the depletion of senescent cells in older…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 24
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences